Fundz

Farmako raised $1.6M in an Angel funding round led by 535 West Capital and others to expand its quick medicine delivery services in Delhi and Gurugram.

PRIVATEAug 12, 2024

Amount Raised

$1.6 Million

Round Type

Angel

GurugramInformation TechnologyHealth CareArtificial IntelligenceMedical

Investors

Jude GomilaUnpopular VenturesGoodwater CapitalBayhouse Capital535 West Capital

Description

Gurugram-based healthtech startup Farmako has raised $1.6 million from multiple investors, including 535 West Capital and Goodwater Capital. The fresh funding will be used to further expand its operations into Delhi and Gurugram.

Quick answer

Farmako raised $1.6 Million in a Angel round, dated August 12, 2024. Investors: Jude Gomila, Unpopular Ventures, Goodwater Capital, Bayhouse Capital and 535 West Capital. Farmako is based in Gurugram, Haryana, India.

How much did Farmako raise?
Farmako raised $1.6 Million in a Angel round on August 12, 2024.
Who invested in Farmako?
Jude Gomila, Unpopular Ventures, Goodwater Capital, Bayhouse Capital and 535 West Capital are named as investors in this round.
What does Farmako do?
India's fastest medicine delivery in just 30 minutes.
Where is Farmako based and how big is it?
Farmako is based in Gurugram, Haryana, India.
Who are the decision-makers at Farmako?
Fundz holds 1 contact at Farmako. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Health Care around the same time

Companies in the same sectors as Farmako that raised within 45 days of this round, from Fundz verified event records.

  • Mediwhale raised $12M (Series A) on September 25, 2024.
  • Sparrow BioAcoustics raised $13M (Seed) on September 20, 2024.
  • Cercle raised $6M (Seed) on September 19, 2024.
  • Ikerian raised $700K on September 13, 2024.
  • SoundHealth raised $7M (Seed) on July 24, 2024.
  • Huma Therapeutics raised $80M (Series D) on July 16, 2024.

Who to call at Farmako, and when

A new round usually means Farmako is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Farmako raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Farmako, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Farmako. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Farmako

Location

Gurugram, Haryana, India

About

India's fastest medicine delivery in just 30 minutes. We are currently available 24/7 in New Delhi, Gurgaon, and Moradabad.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Farmako raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Farmako's next move

See what Strategic adds

Farmako raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.